Sequential phase II Southwest Oncology Group studies (S0012 and S0301) of daunorubicin and cytarabine by continuous infusion, without and with cyclosporine, in older patients with previously untreated acute myeloid leukemia (AML)

PURPOSE: Attempts to overcome multi-drug resistance (MDR) have been limited by toxicities. To investigate the effect of reducing peak drug levels, we performed sequential studies using continuous infusion daunorubicin and cytarabine without (AD) and then with cyclosporine (ADC) in older patients wit...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Chauncey, Thomas R., Gundacker, Holly, Shadman, Mazyar, List, Alan F., Dakhil, Shaker R., Erba, Harry P., Slovak, Marilyn L., Chen, I-Ming, Willman, Cheryl L., Kopecky, Kenneth J., Appelbaum, Frederick R.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2009
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2967366/
https://ncbi.nlm.nih.gov/pubmed/19821823
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2141.2009.07919.x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller